Todd Michael Wood
CIK 1739840 · President of U.S. Operations · last filed 2024-09-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DMTK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
5421 AVENIDA ENCINAS, SUITE F
SAN DIEGO, CA 92008
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALIMERA SCIENCES INC (ALIM) Delisted | President of U.S. Operations | — | $5.54 | — | $0 | 2 | 2024-03-13 |
| DermTech, Inc. (DMTK) Delisted | Chief Commercial Officer | 284,757 | $0.09 | $26.8K | -$1.32M | 28 | 2023-06-14 |
| Vyome Holdings, Inc (OBLN) Delisted | Vice President of Sales | 1,831 | $9.15 | $16.8K | $0 | 2 | 2018-08-27 |
Recent Filings · Page 3 of 4
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-15 | DermTech, Inc. (DMTK) Delisted | Sell (S) | −4,783 | -$197.6K | EDGAR |
| 2021-06-10 | DermTech, Inc. (DMTK) Delisted | Sell (S) | −425 | -$18.5K | EDGAR |
| 2021-05-27 | DermTech, Inc. (DMTK) Delisted | Sell (S) | −10,000 | -$400.0K | EDGAR |
| 2021-04-14 | DermTech, Inc. (DMTK) Delisted | Sell (S) | −10,000 | -$463.3K | EDGAR |
| 2021-03-31 | DermTech, Inc. (DMTK) Delisted | Grant (A) | +8,162 | $0 | EDGAR |
| 2021-03-10 | DermTech, Inc. (DMTK) Delisted | Sell (S) | −417 | -$20.9K | EDGAR |
| 2020-12-10 | DermTech, Inc. (DMTK) Delisted | Sell (S) | −428 | -$5.1K | EDGAR |
| 2020-09-14 | DermTech, Inc. (DMTK) Delisted | Sell (S) | −1,345 | -$14.6K | EDGAR |
| 2020-06-26 | DermTech, Inc. (DMTK) Delisted | Grant (A) | +15,952 | $0 | EDGAR |
| 2020-01-22 | DermTech, Inc. (DMTK) Delisted | Grant (A) | +14,647 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.